< Back
Richard Dunham

Richard Dunham

Director, HIV Cure at ViiV Healthcare
United Kingdom

Richard Dunham, PhD, is Director, HIV Cure at ViiV Healthcare and has 20 years of experience in HIV research and drug discovery in both academia and industry. He joined GSK and ViiV Healthcare in 2013 to lead projects aimed at treating persistent inflammation in people living with HIV and eliminating HIV reservoirs. He currently directs HIV cure, clinical/translational immunology and therapeutic vaccines efforts at ViiV. He earned his PhD at Emory University and conducted postdoctoral training at the University of California, San Francisco.

Quick links to our activities

Closing scientific gaps

Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global HIV Vaccine Enterprise Towards an HIV Cure

Disseminating the latest research

IAS Educational Fund Journal of the International AIDS Society (JIAS)

Improving health services

Community-Led Monitoring Differentiated Service Delivery Heart of Stigma Mark Wainberg Fellowship Programme Person-Centred Care Youth Hub

Conferences

International AIDS Conference IAS Conference on HIV Science HIV Research for Prevention Conference

Get involved

Become an IAS change maker Corporate Partnership Programme Me and My Healthcare Provider IAS membership

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.